- Home
- ZUMZ vs NPCE Comparison
ZUMZ vs NPCE Comparison
Compare ZUMZ & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZUMZ
- NPCE
- Stock Information
- Founded
- ZUMZ 1978
- NPCE 1997
- Country
- ZUMZ United States
- NPCE United States
- Employees
- ZUMZ N/A
- NPCE N/A
- Industry
- ZUMZ Clothing/Shoe/Accessory Stores
- NPCE Medical Specialities
- Sector
- ZUMZ Consumer Discretionary
- NPCE Health Care
- Exchange
- ZUMZ Nasdaq
- NPCE Nasdaq
- Market Cap
- ZUMZ 275.3M
- NPCE 292.9M
- IPO Year
- ZUMZ 2005
- NPCE 2021
- Fundamental
- Price
- ZUMZ $17.19
- NPCE $9.15
- Analyst Decision
- ZUMZ Hold
- NPCE Strong Buy
- Analyst Count
- ZUMZ 1
- NPCE 6
- Target Price
- ZUMZ $25.00
- NPCE $16.67
- AVG Volume (30 Days)
- ZUMZ 158.7K
- NPCE 200.8K
- Earning Date
- ZUMZ 09-04-2025
- NPCE 08-12-2025
- Dividend Yield
- ZUMZ N/A
- NPCE N/A
- EPS Growth
- ZUMZ N/A
- NPCE N/A
- EPS
- ZUMZ 0.04
- NPCE N/A
- Revenue
- ZUMZ $896,157,000.00
- NPCE $88,570,000.00
- Revenue This Year
- ZUMZ $3.31
- NPCE $22.13
- Revenue Next Year
- ZUMZ $1.34
- NPCE $6.07
- P/E Ratio
- ZUMZ $436.07
- NPCE N/A
- Revenue Growth
- ZUMZ 3.01
- NPCE 23.32
- 52 Week Low
- ZUMZ $11.31
- NPCE $5.45
- 52 Week High
- ZUMZ $31.37
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- ZUMZ 63.85
- NPCE 51.74
- Support Level
- ZUMZ $15.37
- NPCE $8.61
- Resistance Level
- ZUMZ $18.46
- NPCE $8.99
- Average True Range (ATR)
- ZUMZ 0.74
- NPCE 0.53
- MACD
- ZUMZ 0.17
- NPCE 0.11
- Stochastic Oscillator
- ZUMZ 69.69
- NPCE 75.00
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.